(Q40721554)

23 September 2017

Second-line chemotherapy with mitoxantrone as a single agent in metastatic breast cancer (English)

1 reference

23 September 2017

metastatic breast cancer

1 reference

Brufman G

1

1 reference

23 September 2017

Haim N

series ordinal

2

1 reference

23 September 2017

Ben-Baruch N

series ordinal

3

1 reference

23 September 2017

Sulkes A

series ordinal

4

1 reference

23 September 2017

language of work or name

1 reference

1 February 1993

1 reference

23 September 2017

Journal of Chemotherapy

1 reference

23 September 2017

5

1 reference

23 September 2017

1

1 reference

23 September 2017

43-46

1 reference

Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patients.

23 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739208

Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739208

Evaluation of the binding of some substituted anthraquinones and naphthacenequinones to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739208

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739208

Mitoxantrone (novantrone): a review of experimental and early clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739208

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739208

A comparison of mitoxantrone and doxorubicin in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739208

Dihydroxyanthracenedione: A Promising New Drug in the Treatment of Metastatic Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739208

10.1080/1120009X.1993.11739208

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference